ghk-cu peptide injectable Expanding Therapy Access GHK-CU – Research Peptide |

The safety profile of DSIP rests largely on older animal studies and a limited number of small human studies

This peptide is intended for use by qualified professionals conducting structured research within appropriate laboratory environments

In senescent cells, FOXO4 binds to p53 and prevents apoptosis, allowing these damaged cells to persist

Despite the research saying that MOTS-c may be useful as a cancer therapy, other studies have made contradicting claims that it can lead to the development of prostate and breast cancer.43 Our known providers likewise warn that people with an active cancer diagnosis should avoid MOTS-c unless otherwise recommended by their doctor

Produced under strict quality standards, it offers reliable performance for a wide range of research models

It has been investigated for its involvement in angiogenic signaling , where it is referenced in the literature as a modulator of vascular growth factor pathways